SHOC2 and RASopathy: Together, these results indicate that even relatively modest fourfold to fivefold changes in affinity caused by some of these mutations can modulate MAPK signalling sufficiently to cause disease, and that altered SHOC2–PP1C–RAS complex association is the biochemical cause of a substantial portion of identified RASopathies.